NATCO PHARMA LTD. - 524816 - Related Party Transactions For The Half Year Ended September 30,2019
Related Party Transactions for the half year ended September 30,201906-12-2019
NATCO PHARMA LTD. - 524816 - Related Party Transactions For The Half Year Ended September 30,2019
Related Party Transactions for the half year ended September 30,2019NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Intimation of completion of InvestmentNATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation Q2 FY 2019-20Natco Pharma's Vizag unit begins operations
Natco Pharma Ltd's finished dosage formulations facility in Visakhapatnam has commenced commercial operations, the company said. The facility is a paNatco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Commercial Manufacturing Operations begin in NATCO's Visakhapatnam Formulation FacilityNatco Pharma Ltd - 524816 - Fixes Record Date for Second Interim Dividend
Natco Pharma Ltd has informed BSE that the Company has fixed November 22, 2019 as the Record Date for the purpose of Payment of Second Interim Dividend.The said interim dividend pay-by-date is on or before November 29, 2019.Natco Pharma Q2 net down 35% at Rs 118 cr
Natco Pharma Ltd's consolidated net profit declined 35 per cent at Rs 118 crore in the second quarter ended September 30, 2019 compared to Rs 182 croNatco Pharma Ltd - 524816 - Board declares Second Interim Dividend
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 12, 2019, inter alia, have considered and approved the following business:- Declaration of second interim dividend of Rs. 1 (Rupees one only) per equity share of Rs. 2/- each for the financial year 2019-20. The said interim dividend pay-by-date is on or before November 29, 2019.Natco Pharma Ltd - 524816 - Corporate Action-Board to consider Dividend
22nd November, 2019 is fixed as Record date for payment of 2nd Interim Dividend for the year 2019-2020Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
NATCO records INR 518.9 Crore consolidated revenue and INR 117.7 Crore of profit, after tax, for the Second Quarter, FY2019-20